A Fuzzy Logic–Based Intelligent System for Early Risk Identification of Pancreatic Ductal Adenocarcinoma

Abstract Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive malignancies, often diagnosed at an advanced stage due to the absence of early clinical symptoms. Early identification and risk stratification are therefore crucial to improving patient outcomes and survival rates. This study presents an intelligent decision-support system based on fuzzy logic for the early identification and categorization of PDAC risk using patient clinical data. Key input parameters such as age at diagnosis, tumor classification, treatment type, and vital status are incorporated into a Fuzzy Inference System (FIS). The proposed model classifies patients into Low, Medium, and High-Risk groups using a transparent rule-based reasoning mechanism. The Mamdani-type fuzzy logic approach enables effective handling of uncertainty and imprecision inherent in medical data, while maintaining interpretability for clinical decision-making. Experimental evaluation demonstrates that the proposed system can effectively support early risk assessment and assist clinicians in diagnosis and treatment planning. The results highlight the potential of fuzzy logic–based models as reliable and interpretable tools for early PDAC risk prediction.

Authors

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-03-11
DOI
https://doi.org/10.5281/zenodo.18950710
Primary Topic
Pancreatic and Hepatic Oncology Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Fuzzy Logic–Based Intelligent System for Early Risk Identification of Pancreatic Ductal Adenocarcinoma

Dr. Dnyaneshwari Patil, Rewati Rane
Zenodo (CERN European Organization for Nuclear Research)
Pancreatic and Hepatic Oncology Research
article

A Fuzzy Logic–Based Intelligent System for Early Risk Identification of Pancreatic Ductal Adenocarcinoma

Dr. Dnyaneshwari Patil, Rewati Rane
article en

Abstract

Abstract Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive malignancies, often diagnosed at an advanced stage due to the absence of early clinical symptoms. Early identification and risk stratification are therefore crucial to improving patient outcomes and survival rates. This study presents an intelligent decision-support system based on fuzzy logic for the early identification and categorization of PDAC risk using patient clinical data. Key input parameters such as age at diagnosis, tumor classification, treatment type, and vital status are incorporated into a Fuzzy Inference System (FIS). The proposed model classifies patients into Low, Medium, and High-Risk groups using a transparent rule-based reasoning mechanism. The Mamdani-type fuzzy logic approach enables effective handling of uncertainty and imprecision inherent in medical data, while maintaining interpretability for clinical decision-making. Experimental evaluation demonstrates that the proposed system can effectively support early risk assessment and assist clinicians in diagnosis and treatment planning. The results highlight the potential of fuzzy logic–based models as reliable and interpretable tools for early PDAC risk prediction.

Zenodo (CERN European Organization for Nuclear Research)
Samjin Pharm (South Korea) (KR), MIT Art, Design and Technology University (IN)
Peace, Justice and strong institutions
Openalex Percentile: Top 26%
Pancreatic and Hepatic Oncology Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.